Sacubitril-valsartan: Hope or hype in the battle against cardiotoxicity due to cancer treatment? Authors' reply.
作者信息
Sławiński Grzegorz, Lewicka Ewa
机构信息
Department of Cardiology and Electrotherapy, Medical University of Gdansk, Gdańsk, Poland.
出版信息
Kardiol Pol. 2022;80(9):960-961. doi: 10.33963/KP.a2022.0196. Epub 2022 Aug 18.
PMID:35979643
Abstract
摘要
相似文献
1
Sacubitril-valsartan: Hope or hype in the battle against cardiotoxicity due to cancer treatment? Authors' reply.沙库巴曲缬沙坦：对抗癌症治疗所致心脏毒性之战中的希望还是炒作？作者回复。
Kardiol Pol. 2022;80(9):960-961. doi: 10.33963/KP.a2022.0196. Epub 2022 Aug 18.
2
Sacubitril-valsartan: Hope or hype in the battle against cardiotoxicity due to cancer treatment?沙库巴曲缬沙坦：对抗癌症治疗所致心脏毒性之战中的希望还是炒作？
Kardiol Pol. 2022;80(9):958-959. doi: 10.33963/KP.a2022.0166. Epub 2022 Jul 14.
3
Sacubitril/Valsartan and Rhabdomyolysis: Reanalysis of a Potential Safety Signal.沙库巴曲缬沙坦与横纹肌溶解症：对潜在安全信号的重新分析
Am J Cardiol. 2022 Jun 15;173:145-146. doi: 10.1016/j.amjcard.2022.03.015. Epub 2022 Apr 13.
4
Strength in synergy: Cardiometabolic effects of sacubitril/valsartan in heart failure and diabetes.协同作用的力量：沙库巴曲缬沙坦对心力衰竭合并糖尿病患者的心脏代谢效应
Int J Cardiol. 2023 Jan 15;371:293-294. doi: 10.1016/j.ijcard.2022.09.019. Epub 2022 Sep 15.
5
Sacubitril/Valsartan-induced Angioedema.沙库巴曲缬沙坦所致血管性水肿。
Intern Med. 2024;63(18):2583. doi: 10.2169/internalmedicine.3183-23. Epub 2024 Sep 15.
6
Association Between Sacubitril/Valsartan Initiation and Mitral Regurgitation Severity in Heart Failure With Reduced Ejection Fraction: The PROVE-HF Study.沙库巴曲缬沙坦起始治疗与射血分数降低的心力衰竭患者二尖瓣反流严重程度之间的关联：PROVE-HF研究
Circulation. 2022 Nov 22;146(21):1638-1640. doi: 10.1161/CIRCULATIONAHA.122.061693. Epub 2022 Oct 2.
7
Adoption of Sacubitril/Valsartan Among Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The Get With The Guidelines-Heart Failure Registry.沙库巴曲缬沙坦在射血分数轻度降低或保留的心力衰竭患者中的应用：“遵循指南-心力衰竭”注册研究
Circ Heart Fail. 2023 Jan;16(1):e010176. doi: 10.1161/CIRCHEARTFAILURE.122.010176. Epub 2022 Oct 31.
8
Meet Me in the Middle: Lessons From the Cardiorenal Advisory Committee for Sacubitril/Valsartan in HFpEF.达成共识：来自心脏肾脏咨询委员会关于沙库巴曲缬沙坦治疗射血分数保留的心力衰竭的经验教训。
JACC Heart Fail. 2021 Feb;9(2):161-163. doi: 10.1016/j.jchf.2020.12.003.
9
Sacubitril/valsartan-induced liver injury: A case report and literature review.沙库巴曲缬沙坦致肝损伤：1 例报告并文献复习。
Medicine (Baltimore). 2023 Aug 11;102(32):e34732. doi: 10.1097/MD.0000000000034732.
10
Three cases of psychosis after use of sacubitril/valsartan.使用沙库巴曲缬沙坦后出现的三例精神病病例。
Rev Esp Cardiol (Engl Ed). 2021 Jan;74(1):103-105. doi: 10.1016/j.rec.2020.05.033. Epub 2020 Jul 29.
Zotero 插件